13F Holdings
中文EN

ZTEKF Zentek Ltd. IFRS Annual reports only

Miscellaneous Chemical Products · OTC · SEC CIK 1904501 · Reporting currency CAD · Fiscal year ends 03/31

Financial factors as of 2025-03-31 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY2,826.3%
TTM net income YoY14.2%
TTM EPS YoY16.7%
Revenue 3-yr CAGR36.0%
Net income 3-yr CAGR—

Margins

Gross margin26.1%
Operating margin-1,100.9%
Net margin-1,150.7%
FCF margin-720.2%
EBITDA margin-1,032.1%

Returns

ROE-57.5%
ROA-49.0%
ROIC (approx.)-46.9%
Asset turnover0.04x

Leverage & solvency

Liabilities / assets19.8%
Debt / equity0.02x
Current ratio1.25x
Interest coverage-105.18x

Cash quality & payout

Operating cash flow / net income0.63x
Accruals ratio-18.3%
Payout ratio—
Capex / revenue0.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Unit: CAD FY2025*2025-03-31FY2024*2024-03-31FY2023*2023-03-31FY2022*2022-03-31FY2021*2021-03-31
Income statement
Revenue872,49529,81672,855347,1832,355
Cost of revenue644,610289,011———
Gross profit227,885-259,195———
R&D expense465,6531.78M1.65M1.54M0
Operating income-9.61M-12.40M-14.97M-12.56M-4.31M
Interest expense91,323107,373120,62463,7776,460
Income tax00000
Net income-10.04M-11.70M-14.41M-31.69M-3.87M
EBITDA-9.01M-11.79M-14.43M——
EPS (basic)-0.10-0.12-0.14-0.34—
EPS (diluted)-0.10-0.12-0.14-0.340.05
Balance sheet
Cash & equivalents121,4813.52M10.36M26.68M3.09M
Receivables1.20M296,530569,008656,164119,349
Inventory887,5091.42M2.85M665,5720
Current assets4.37M6.25M17.95M31.96M3.39M
PP&E, netmay include right-of-use assets (IFRS)5.28M7.77M8.34M6.03M705,221
Total assets18.40M22.59M33.29M44.98M30.25M
Current liabilities3.49M1.82M2.42M2.30M2.51M
Short-term debt346,747498,613998,080950,9300
Long-term debt0259,1140998,0700
Total debt346,747757,727998,0801.95M0
Total liabilities3.65M2.41M2.90M3.44M2.79M
Shareholders' equity14.75M20.17M30.38M41.55M27.46M
Net debt225,266-2.76M-9.36M-24.73M-3.09M
Cash flow statement
Operating cash flow-6.28M-8.05M-12.96M-7.99M-1.79M
Capital expenditure1,398320,0992.27M3.99M254,282
Free cash flow-6.28M-8.37M-15.23M-11.97M-2.05M
Investing cash flow358,6511.88M-2.31M-7.25M—
Financing cash flow2.52M-665,470-1.05M38.82M5.31M
Depreciation & amortization600,322613,714539,693——
Stock-based compensation1.53M1.79M3.20M4.73M2.02M

· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· Amounts are in the company's reporting currency, CAD, not USD; the site does no currency conversion.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.